Dr Lal PathLabs Gears Up for Q3 Reveal on 30th January; Check Key Expectations Here
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 29 Jan 2026 • 6:40 pm
Posted by:
Dr Lal PathLabs' Q3 results FY26 are scheduled to be announced on 30th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Dr Lal PathLabs Q3 Results 2026 Preview
- Dr Lal PathLabs' revenue is expected to be in the range of ₹596.70 crore, a 9.62% YoY increase.
- Profit After Tax, or PAT, is projected to fall by 25.15% YoY.
- Net profit is ₹96.70 crore, fall 25.15% YoY
- EBITDA to fall 29.13%
Dr Lal PathLabs Share Performance
- Over the past six months, Dr Lal PathLabs' share price has fallen by 8.95% to ₹28.00.
- Moreover, over the past year, the stock has increased by 12.87%.
- Despite this weak short-term performance, Dr Lal PathLabs' stock has delivered a financially sound 239.85% return over the past 5 years.
- As of 29th January 2026, the stock traded at ₹28.00 per share.
Key Factors to Watch for Dr Lal PathLabs Q3 Results FY26
- Revenue & Volume Growth: Track topline expansion and growth in routine and specialised test volumes.
- Profitability & Margins: Monitor EBITDA and PAT trends amid cost pressures.
- High‑Value Tests: Assess contribution from premium diagnostics and health packages.
- Network Expansion & Utilisation: Monitor new labs and patient service centres, and their utilisation.
- Operational Efficiency: Track lab setup, staffing, and technology investments affecting margins.
Final Thoughts
Dr Lal PathLabs will announce its Q3 FY26 results on 30th January 2026. Analysts expect 4.30% YoY revenue growth, a 1.67% rise in PAT, and a 4.33% fall in EBITDA. Dr Lal PathLabs focuses on delivering comprehensive diagnostic and healthcare services through a wide network of labs and advanced testing solutions across India.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Recent Articles
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
30 October 2026
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
30 October 2026
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
30 October 2026
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
30 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
Asian Paints Share Price After Q2 Results: Profit Up 7%, but Price Hikes Are Yet to Brighten Margins
Popular this week
Borosil Share Price Jumps 16% After Strong Q2 Results: Record Profit, Margin Jump and Key Price Levels to Know
Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times